News

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

-Validation Studies Confirmed the Assay Can Detect Mpox Clade I and Clade Ib in addition to Clade II- STONY BROOK,…

1 year ago

Nava Health Announces Expansion to Annapolis, Maryland

COLUMBIA, MD / ACCESSWIRE / August 23, 2024 / Nava Health, a leader in longevity, integrative, and functional medicine, is…

1 year ago

Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…

1 year ago

Trichome Analytical Appoints Industry Leader Sarah Ahrens as Partner and President, Strengthening Commitment to Cannabis Quality and Transparency

MOUNT LAUREL, NJ / ACCESSWIRE / August 23, 2024 / Trichome Analytical, a leading provider of cannabis testing and compliance…

1 year ago

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has…

1 year ago

OKYO Pharma CEO Interview to Air on Bloomberg TV

LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing…

1 year ago

CytoDyn Engages Leading CRO For Phase II Inflammation Trial

VANCOUVER, Washington, Aug. 23, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab,…

1 year ago

WORK Medical Technology Group LTD Announces Pricing of Initial Public Offering

Hangzhou, China, Aug. 23, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (the "Company"), a supplier of medical devices…

1 year ago

European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma

First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial…

1 year ago

Repligen Corporation to Present at Wells Fargo Healthcare Conference

WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,…

1 year ago